Paxman AB (publ) (B0F.F)
- Previous Close
6.90 - Open
6.96 - Bid 6.96 x --
- Ask 7.26 x --
- Day's Range
6.96 - 6.96 - 52 Week Range
3.36 - 7.26 - Volume
958 - Avg. Volume
215 - Market Cap (intraday)
150.446M - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
36.63 - EPS (TTM)
0.19 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.
paxmanscalpcooling.comRecent News: B0F.F
View MorePerformance Overview: B0F.F
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: B0F.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: B0F.F
View MoreValuation Measures
Market Cap
146.85M
Enterprise Value
144.46M
Trailing P/E
36.09
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.74
Price/Book (mrq)
9.71
Enterprise Value/Revenue
6.23
Enterprise Value/EBITDA
26.77
Financial Highlights
Profitability and Income Statement
Profit Margin
15.27%
Return on Assets (ttm)
10.62%
Return on Equity (ttm)
28.05%
Revenue (ttm)
263.2M
Net Income Avi to Common (ttm)
40.2M
Diluted EPS (ttm)
0.19
Balance Sheet and Cash Flow
Total Cash (mrq)
40.31M
Total Debt/Equity (mrq)
8.72%
Levered Free Cash Flow (ttm)
1.26M